BIOCRYST PHARMACEUTICALS INC - COM (BCRX)

Historical Portfolio Holders from Q1 2014 to Q1 2024

All holders as of March 31, 2024
Q1 2024
Type / Class
Equity / COM
Shares, excl. options Q1 2024
177 M
Holdings value Q1 2024
$897 M
Value change Q1 2024
+$13.5 M
Grand Portfolio weight change Q1 2024
+0%
Number of holders
228
Number of buys Q1 2024
112
Number of sells Q1 2024
-94
Average buys Q1 2024 %
+0.001%
Average sells Q1 2024 %
0%
CUSIP
09058V103
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Period Shares, Excl. Options Value, Excl. Options Change Price Investors
2024 Q1 177 M $897 M +$13.5 M $5.08 228
2023 Q4 173 M $1.04 B -$53.9 M $5.99 231
2023 Q3 174 M $1.23 B +$20.6 M $7.08 228
2023 Q2 173 M $1.22 B +$8.68 M $7.04 229
2023 Q1 170 M $1.42 B +$92.1 M $8.34 236
2022 Q4 156 M $1.79 B +$88.2 M $11.48 222
2022 Q3 147 M $1.85 B -$41.6 M $12.60 210
2022 Q2 146 M $1.55 B +$166 M $10.58 198
2022 Q1 127 M $2.06 B +$166 M $16.26 214
2021 Q4 116 M $1.6 B +$193 M $13.85 193
2021 Q3 103 M $1.48 B -$24.1 M $14.37 192
2021 Q2 105 M $1.65 B +$17.8 M $15.81 187
2021 Q1 104 M $1.06 B -$140 M $10.17 184
2020 Q4 121 M $898 M -$44.5 M $7.45 172
2020 Q3 127 M $438 M -$23.5 M $3.44 148
2020 Q2 131 M $623 M +$86.6 M $4.76 156
2020 Q1 122 M $245 M -$37.6 M $2.00 125
2019 Q4 136 M $471 M +$129 M $3.45 126
2019 Q3 97.2 M $278 M -$6.77 M $2.87 105
2019 Q2 99.8 M $378 M -$88.3 M $3.79 107
2019 Q1 101 M $820 M -$625 K $8.14 124
2018 Q4 101 M $814 M +$8.36 M $8.07 114
2018 Q3 100 M $764 M +$74.2 M $7.63 108
2018 Q2 87.4 M $501 M -$8.95 M $5.73 94
2018 Q1 89 M $425 M -$6.56 M $4.77 97
2017 Q4 90.3 M $443 M +$31.9 M $4.91 110
2017 Q3 83.5 M $436 M +$74.6 M $5.24 115
2017 Q2 68.6 M $382 M +$5.09 M $5.56 110
2017 Q1 67.6 M $566 M +$138 M $8.40 114
2016 Q4 58.3 M $369 M +$11.8 M $6.33 113
2016 Q3 56.5 M $249 M +$24.6 M $4.41 99
2016 Q2 51.2 M $145 M -$10.4 M $2.84 88
2016 Q1 53.8 M $152 M -$59.5 M $2.83 97
2015 Q4 62.9 M $650 M -$41.8 M $10.32 113
2015 Q3 63.7 M $726 M +$33.9 M $11.40 122
2015 Q2 62.2 M $929 M +$39.2 M $14.93 118
2015 Q1 58 M $524 M +$37.8 M $9.03 95
2014 Q4 53.7 M $652 M +$25.6 M $12.16 87
2014 Q3 56.7 M $554 M -$6.98 M $9.78 100
2014 Q2 49.8 M $635 M +$146 M $12.75 96
2014 Q1 43.5 M $460 M +$93.2 M $10.58 84